Insmed Inc annual free cash flow for fiscal TTM was -$837 million, an increase of 13.5% from -$968 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($837M) | ($968M) | ($706M) | ($550M) | ($410M) | ($371M) | ($226M) | ($293M) | ($273M) | ($163M) | ($151M) | ($104M) | ($70M) | ($47M) | ($31M) | ($31M) | ($14M) | ($11M) | ($12M) | ($25M) | ($47M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($95M) | ($226M) | ($294M) | ($222M) | ($209M) | ($272M) | ($203M) | ($185M) | ($130M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More INSM metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All INSM financial statements → Interactive INSM charts →
About TickerBase · Data methodology & sources · Privacy · Terms